Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors Journal:Journal for ImmunoTherapy of Cancer | 2021 | 18 | ||
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib Journal:Expert Review of Gastroenterology and Hepatology | 2021 | 12 | ||
The outcomes of systemic treatment in recurrent hepatocellular carcinomas following liver transplants Journal:Advances in Therapy | 2021 | 10 | ||
2021 | 9 | |||
2021 | 20 |